In individuals with irritable bowel syndrome, chrons disease, and ulcerative colitis, intravenous and intramuscular routes may be preferred
Thanks to advances in technology, accessing expert medical advice has never been easier
Butyrate, a SCFA from fiber fermentation, slows digestion and increases GLP-1 production (Huber et al, 2024
One of the major trials of tirzepatide (the active ingredient in Zepbound and Mounjaro) revealed that participants lost an average of 15% to 21% of their body weight over a period of 72 weeks
This unique technology revolutionizes intimate health and wellness by providing those suffering from incontinence with a completely non-invasive option CONTACT US Book in your free consultation with one of our specialists (we speak English, Ukrainian and Russian)
Circulation 2012;126:300816